Karimah Es Sabar's most recent trade in Capricor Therapeutics Inc was a trade of 7,529 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on April 2, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Capricor Therapeutics Inc | Karimah Es Sabar | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Apr 2026 | 7,529 | 161 | - | - | Stock Option (Right to Buy) | |
| Capricor Therapeutics Inc | Karimah Es Sabar | Director | Sale of securities on an exchange or to another person at price $ 32.00 per share. | 02 Apr 2026 | 7,529 | 0 (0%) | 0% | 32 | 240,928 | Common Stock |
| Capricor Therapeutics Inc | Karimah Es Sabar | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.18 per share. | 02 Apr 2026 | 7,529 | 7,529 (0%) | 0% | 3.2 | 23,942 | Common Stock |
| Capricor Therapeutics Inc | Karimah Es Sabar | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.86 per share. | 31 Mar 2026 | 61,265 | 61,265 (1%) | 1% | 4.9 | 297,748 | Common Stock |
| Capricor Therapeutics Inc | Karimah Es Sabar | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2026 | 61,265 | 53,735 | - | - | Stock Option (Right to Buy) | |
| Capricor Therapeutics Inc | Karimah Es Sabar | Director | Sale of securities on an exchange or to another person at price $ 30.17 per share. | 31 Mar 2026 | 61,265 | 0 (0%) | 1% | 30.2 | 1,848,243 | Common Stock |
| Capricor Therapeutics Inc | Karimah Es Sabar | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.86 per share. | 31 Mar 2026 | 53,735 | 53,735 (1%) | 1% | 4.9 | 261,152 | Common Stock |
| Capricor Therapeutics Inc | Karimah Es Sabar | Director | Sale of securities on an exchange or to another person at price $ 31.03 per share. | 31 Mar 2026 | 53,735 | 0 (0%) | 1% | 31.0 | 1,667,225 | Common Stock |
| Capricor Therapeutics Inc | Karimah Es Sabar | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2026 | 53,735 | 0 | - | - | Stock Option (Right to Buy) | |
| Capricor Therapeutics Inc | Karimah Es Sabar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 15,500 | 15,500 | - | - | Stock Option (Right to Buy) | |
| Capricor Therapeutics Inc | Karimah Es Sabar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 11,940 | 11,940 | - | - | Stock Option (Right to Buy) | |
| Capricor Therapeutics Inc | Karimah Es Sabar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 5,750 | 5,750 | - | - | Stock Option (Right to Buy) | |
| Capricor Therapeutics Inc | Karimah Es Sabar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 2,520 | 2,520 | - | - | Stock Option (Right to Buy) | |
| Capricor Therapeutics Inc | Karimah Es Sabar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 29,250 | 29,250 | - | - | Stock Option (Right to Buy) | |
| Capricor Therapeutics Inc | Es Sabar Karimah | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 14,280 | 14,280 | - | - | Stock Option (Right to Buy) | |
| Capricor Therapeutics Inc | Es Sabar Karimah | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 4,460 | 4,460 | - | - | Stock Option (Right to Buy) | |
| Capricor Therapeutics Inc | Karimah Es Sabar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 3,560 | 3,560 | - | - | Stock Option (Right to Buy) | |
| Capricor Therapeutics Inc | Karimah Es Sabar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 7,690 | 7,690 | - | - | Stock Option (Right to Buy) | |
| Capricor Therapeutics Inc | Karimah Es Sabar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jul 2021 | 115,000 | 115,000 | - | - | Stock Option (Right to Buy) |